The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 01, 2015

Filed:

Nov. 19, 2010
Applicant:

Jacques Leibowitch, Paris, FR;

Inventor:

Jacques Leibowitch, Paris, FR;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/675 (2006.01); A61K 31/52 (2006.01); A61P 31/18 (2006.01); A61K 38/07 (2006.01); A61K 31/635 (2006.01); A61K 31/538 (2006.01); A61K 31/708 (2006.01); A61K 31/665 (2006.01); A61K 31/536 (2006.01); A61K 31/34 (2006.01); A61K 31/426 (2006.01); A61K 31/4418 (2006.01); A61K 31/505 (2006.01); A61K 31/513 (2006.01); A61K 31/661 (2006.01); A61K 31/7068 (2006.01);
U.S. Cl.
CPC ...
A61K 31/536 (2013.01); A61K 31/34 (2013.01); A61K 31/426 (2013.01); A61K 31/4418 (2013.01); A61K 31/505 (2013.01); A61K 31/513 (2013.01); A61K 31/52 (2013.01); A61K 31/661 (2013.01); A61K 31/675 (2013.01); A61K 31/7068 (2013.01);
Abstract

The invention relates to a pharmaceutical composition for treating the human immunodeficiency virus (HIV) in humans, including three or four active principles selected as: a nucleoside reverse transcriptase inhibitor (NARTI) selected from lamivudine and emtricitabine; a nucleoside or nucleotide reverse transcriptase inhibitor (NARTI) selected from didanosine, abacavir and tenofovir; and the combination of ritonavir with a protease inhibitor (PI) selected from lopinavir, fosamprenavir, atazanavir and darunavir; or an non-nucleoside reverse transcriptase inhibitor (NNRTI) selected from efavirenz and etravirine; for daily administration to said human being one to four days per week.


Find Patent Forward Citations

Loading…